Clinical Research Site 369 — Boston, Massachusetts

Clinical Research Site 369 is a clinical research site located in Boston, Massachusetts, United States 21144.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Research Site 369 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: IgA Nephropathy.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Research Site 369?

Clinical Research Site 369 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Research Site 369 conducted?

Clinical Research Site 369 has 1 clinical trials on record, with 1 currently active. Their work covers IgA Nephropathy.

Is Clinical Research Site 369 accredited by Crixeo Health?

Clinical Research Site 369 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Research Site 369?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.